Literature DB >> 23946499

The effect of combined hyperbaric oxygen and iloprost treatment on the prevention of spinal cord ischaemia-reperfusion injury: an experimental study.

Gokhan Ilhan1, Murat Aksun, Berkan Ozpak, Tevfik Gunes, Sahin Bozok, Murtaza Emre Durakoglugil, Levent Tumkaya, Hasan Gucer, Ali Gurbuz.   

Abstract

OBJECTIVES: Hyperbaric oxygen (HBO) has been shown to be effective in preventing neurological injuries in animal models of ischaemia, whereas iloprost (IL) prevents ischaemia-related mitochondrial dysfunction and reduces infarction size after focal cerebral ischaemia in animal models. The aim of the present study was to investigate the effect of combined HBO and IL treatment on spinal cord ischaemia-reperfusion (IR) injury by neurological, histopathological and biochemical methods in an experimental study.
METHODS: Eighty New Zealand white male rabbits were randomly allocated into one of five study groups. The HBO group received a single session of HBO treatment and the IL group received an infusion of 25 ng/kg/min IL; the HBO + IL group received both HBO and IL and the control group received only 0.9% saline; the fifth group was the sham group. Levels of S100β protein, neuron-specific enolase (NSE) and nitric oxide (NO) were measured at onset, at the end of ischaemia period and at the 24th and 48th hour of reperfusion. Physical activity was assessed using Tarlov criteria 24, and the spinal cords of the sacrificed rabbits were evaluated histopathologically. Additionally, tissue malondialdehyde (MDA) and antioxidant enzyme activities [total superoxide dismutase (SOD); catalase (CAT) and glutathione peroxidase (GSH-Px) were assessed.
RESULTS: Neurological scores in the HBO, IL and HBO + IL groups were statistically significantly better compared with the control group at the 24th (P = 0.001 for all) and 48th hour (P = 0.001 for all). Histopathological scores in the HBO, IL and HBO + IL groups were also significantly better compared with the control group (P = 0.003, 0.001 and 0.001, respectively). Whereas MDA, NSE, S100β protein and NO concentrations were significantly lower, CAT and GSH-PX levels were significantly higher in either sham or treatment groups compared with the control group.
CONCLUSIONS: Since we demonstrated beneficial effects on spinal cord IR injury, we think that both HBO and IL, either alone or in combination, may be reasonable in the treatment of IR injury. Furthermore, there did not appear to be synergistic effects with combined treatment. More research is needed for practical application in humans, following thoracoabdominal aortic surgery.

Entities:  

Keywords:  Hyperbaric oxygen; Iloprost; Ischaemia–reperfusion injury; Spinal cord

Mesh:

Substances:

Year:  2013        PMID: 23946499     DOI: 10.1093/ejcts/ezt398

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Comparison of hyperbaric oxygen versus iloprost treatment in an experimental rat central retinal artery occlusion model.

Authors:  Suleyman Karaman; Berna Ozkan; Yusufhan Yazir; Melda Yardimoglu; Mustafa Gok; Ozgur Kara; Cigdem Vural; Selenay Rencber; Salih K Emek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-02       Impact factor: 3.117

2.  Acute spontaneous spinal cord infarction: Utilisation of hyperbaric oxygen treatment, cerebrospinal fluid drainage and pentoxifylline.

Authors:  Catherine Ashton; Neil Banham; Merrilee Needham
Journal:  Diving Hyperb Med       Date:  2020-12-20       Impact factor: 0.887

3.  Protective Effect of Hyperbaric Oxygen Treatment on Axon Degeneration after Acute Motor Axonal Neuropathy.

Authors:  Ni Komang Sri Dewi Untari; Kurnia Kusumastuti; Guritno Suryokusumo; I Ketut Sudiana
Journal:  Autoimmune Dis       Date:  2021-11-08

4.  Effects of hyperbaric oxygen and iloprost on intestinal ischemia-reperfusion induced acute lung injury.

Authors:  Yeliz Yilmaz; Levent Tumkaya
Journal:  Ann Surg Treat Res       Date:  2018-12-26       Impact factor: 1.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.